320045749 | smh | 29997897 | | 8850939 | 5/24/2007 12:00:00 am | musculoskeletal chest pain | | dis | admission date: 10/16/2007 report status:discharge date: 4/30/2007 final discharge orders rashdi , christopher 223-91-47-1a ment scotservice: meddischarge patient on: 6/6/07 at 04:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: vixayack , emilio jon , m.d.code status:full codedisposition: homemedications on admission:1. aspirin enteric coated 325 mg po qd2. furosemide 60 mg po bid3. metoprolol succinate extended release 50 mg po qd4. simvastatin 20 mg po qhs5. warfarin sodium 6 mg po qpmmedications on discharge:tylenol ( acetaminophen ) 1 , 000 mg po q6hacetylsalicylic acid 81 mg po dailyoverride notice: override added on 7/28/07 byfegueroa , carey e. , m.d.on order for coumadin po ( ref # 057079355 )potentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinreason for override: mda previous override information:override added on 10/28/07 by wademan , osvaldo h. , m.d.on order for coumadin po ( ref # 209100063 )potentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinreason for override: mdaibuprofen 400 mg po q8h food/drug interaction instructiontake with foodlisinopril 2.5 mg po dailyalert overridden: override added on 6/6/07 by :potentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinopril reason for override: okmetoprolol succinate extended release 25 mg po dailyfood/drug interaction instructiontake consistently with meals or on empty stomach.simvastatin 20 mg po bedtimefood/drug interaction instructionavoid grapefruit unless md instructs otherwise.override notice: override added on 7/28/07 bybalette , mckinley r. , m.d.on order for coumadin po ( ref # 057079355 )potentially serious interaction: simvastatin & warfarinreason for override: mda previous override information:override added on 10/28/07 by hoa , fredrick b. , m.d.on order for coumadin po ( ref # 209100063 )potentially serious interaction: simvastatin & warfarinreason for override: mdacoumadin ( warfarin sodium ) 3.5 mg po qpmstarting now , within hour of pharmacy approvalfood/drug interaction instructionno high vitamin-k containing foodsalert overridden: override added on 7/28/07 byzuwkowski , modesto l. , m.d.potentially serious interaction: simvastatin & warfarinpotentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinpotentially serious interaction: aspirin & warfarinreason for override: mdadiet: house / low chol/low sat. fatactivity: walking as toleratedfollow up appointment( s ):dr. connette 3/6/07 , 10:10 am scheduled ,arrange inr to be drawn on 7/27/07 with f/u inr's to be drawn every7 days. inr's will be followed by vlgmho coumadin clinicallergy: nkaadmit diagnosis:chest painprincipal discharge diagnosis ;responsible after study for causing admission )musculoskeletal chest painother diagnosis;conditions , infections , complications , affecting treatment/stayobesity , atrial fibrillation on coumadin , hypertensionoperations and procedures:noneother treatments/procedures ( not in o.r. )cardiac mibi: preliminary results suggest this was a poor study , smallreversible inferior septal defect was thought to likely be artifact.brief resume of hospital course:cc: chest pain---------------------hpi: 60f with afib on coumadin , hypertension. woke up at 10 am with lsided chest and back pain. radiation to arm with motion. +nausea ,+crampy abdominal pain. worse with arm and body movement. has 1 yearh/o progressive sob with exertion and increasing lower extremityedema.---------------------pmh: htnafib diagnosed 2/8echo 2/5 concentric lvh. overall left ventricular function is lownormal to mildly impaired. the estimated ejection fraction is 50%.mild-mod mr mild lae , no pfo/asd.-----------------------meds: zocor lasix coumadin toprol asa-----------------------all: nkda-----------------------sh: remote prior h/o smoking , social alcohol no drugs-----------------------physical on admission: afeb , 48 , 142/74 , 99 onra obese jvp 8-10 cm lungs: cta b/l tenderness to palpation of anterior lchest and posterior l scapular and pain in shoulder with movementirr irr 2/6 sys murmur , feint apical murmur abd: benign ext: chronicvenous stasis changes , trace - 1+ le edema , +tophi-----------------------labs: k 3.3 , cr .9 studies:portable cxr: clear ekg: brady at 48 with multiple atrial foci ,varying pr intervals , different p wave morphology , q's iniii and avf ( change from prior ) , no st changesstress test in 04: no ischemia , 4 minutes on bruce got her to 100% ofpredicted hr-----------------------events: 6/10 w/ transient lbbb----------------------------------hospital course: 60f with htn , afib presents with acute onset l sidedchest/back/shoulder pain , atypical for cardiac cp.1. ischemia: it was felt that patient's chest pain was likelymusculoskeletal. it was worse with movement of her arms and chest and wsreproducible with palapation. she was ruled out for mi with serialenzymes and ekgs. we continued her asa , lowered her dose of bblockergiven bradycardia , and started the patient on an ace inhibitor. sheunderwent ett and went into rate related l bundle branch block. fullreport as follows: 1. peak mets = 5.7 2. duke treadmill score = +4( moderate risk: -10 to +4 ) 3. hr recovery = 29assessment:1. diagnosis: no evidence for ischemia at hr achieved.reduced sensitivity because ecg uninterpretable due to rate related lbbb.2. prognosis: elevated prognostic risk based on low functional capacityand a low duke score of +4 ( moderate risk: -10 to +4 ). 3.arrhythmia:probable rate related lbbb at peak. 4. hemodynamics: normal exercisehemodynamics.cardiology was consulted and they recommended a mibi and echo tobetter evaluate her cardiac function. she then underwent a mibi whichshowed a small inferior septaldefect , which was thought to likely beartifact. given the small area , it was felt medical management would bethe best approach. she was discharged on small dose of bblocker , aceinhibitor asa and statin.pump: the patient's lasix had recently been increased to 60 mg bid. shewas not felt to be volume overloaded and was continued on this dose inhouse. her echo was done on the day of discharge and can be followed upas an outpatient. her blood pressures ran on the low side so she willbe discharged on a lower dose of her bblocker.rhythm: patient has underlying conduction system diseasewith 1 degree av block and developed a left bundle branch block at a hrof 150 during her ett. she was continued on coumadin for h/oafibmusculoskeletal pain: pain improved with standing tylenol and motrinstanding , with oxycodone for breakthroughendocrine: her fasting glucoses showed borderline glucose intolerancewith values around 110. these should be followed as an outpatient.fen: low fat , low salt dietadditional comments: please follow up with you primary care provider. you did not have anysigns of significant heart disease. please call your doctor if yourshortness of breath worsens , you develop new chest pressure , or you feellightheaded.we have started a new medicine for your blood pressure and have loweredthe dose of your other blood pressure medicine.discharge condition: stableto do/plan:f/u final mibi resultsf/u final echo resultsf/u electrolytes on ace-inhibitorconsider pfts to better evaluate reason for progressive shortness ofbreath on exertion ( does not appear to be cardiac in cause )titrate bblocker and ace-inhibitorfollow fasting glucose valuesno dictated summaryentered by: kornblatt , rickey r. , m.d. ( xx759 ) 6/6/07 @ 04:16 pm end of discharge orders 